Advocate Lobbied Lawmakers for Pediatric Cancer Research
Matthew Ceelen pushed for federal funding to support pediatric cancer data and research initiatives.
Updated on Sept. 28, 2026 in Cancer

Live Poll
Should the federal government increase current funding levels for childhood cancer research?
Matthew Ceelen visited Washington D.C. on September 18, 2026, to lobby for the AI for Kids for Cancer Act. The proposed legislation aims to secure $100 million in annual funding for pediatric research efforts.
Why it matters
Advocates are pushing to bridge the funding gap for childhood cancer, which currently receives only 4% of total federal research allocations. This initiative seeks to leverage AI to centralize data and accelerate life-saving breakthroughs.
The proposed bill seeks to authorize $100 million in annual funding over five years for the Childhood Cancer Data Initiative. This comes as federal spending for childhood cancer research remains at approximately 4% of total allocations.
The players
Matthew Ceelen
A student and osteosarcoma survivor who is advocating for increased federal childhood cancer research funding.
Michael McCaul
A U.S. Congressman who serves as the primary sponsor of the AI for Kids for Cancer Act.
MIB Agents
A nonprofit organization dedicated to making it better for children with osteosarcoma through research and advocacy.
Mikaela Naylon
A late teen whose life inspired federal legislative efforts to improve childhood cancer research access.
The details
Teaming with the nonprofit MIB Agents, advocates are promoting the AI for Kids for Cancer Act to integrate advanced technology into pediatric oncology research. The bill aims to modernize how researchers process clinical information to improve outcomes for children facing rare diseases like osteosarcoma.
Timeline
Matthew Ceelen was diagnosed with osteosarcoma in August 2017.
Mikaela Naylon passed away in October 2025.
The Mikaela Naylon Give Kids a Chance Act was signed into law in February 2026.
Congressman Michael McCaul sponsored the AI for Kids for Cancer Act in July 2026.
The advocacy group met with lawmakers on September 18, 2026.
The Big Picture
This legislative push builds directly upon the precedents and advocacy network established by the passage of the Mikaela Naylon Give Kids a Chance Act. By pursuing the AI for Kids for Cancer Act, advocates are extending the federal commitment to pediatric oncology initiated by earlier policy wins.
The proposed legislation could significantly shift the landscape for pediatric oncology treatment by centralizing data access for clinicians. These changes aim to improve the long-term prognosis for children diagnosed with rare conditions by standardizing research and accelerating new therapies.
The takeaway
Advocacy efforts for pediatric cancer research often rely on the personal stories of survivors and families to influence federal budget priorities. Future breakthroughs in treatment remain dependent on sustained investment in data initiatives like those proposed in the recent act.
Further reading
Find more updates on research breakthroughs and policy developments in our Cancer section.
Source note: This article includes information reported by Journal Sentinel.
Live Poll
Should the federal government increase current funding levels for childhood cancer research?










